However, those studies were done on the elderly and not on athletes, so more research needs to be done
Five-year, ten-year, twenty-year safety data doesn't exist yet
In my work as a clinician working in obesity medicine, I see GLP-1 and GIP-based therapies help patients do something that used to feel out of reach: achieve clinically meaningful weight loss while also improving blood pressure, blood sugar, cholesterol, sleep, mobility, and quality of life
Alpha-linolenic acid (ALA) and docosahexaenoic acid (DHA), polyunsaturated omega-3 fatty acids found in flaxseed oil and fish, also increase GLP-1 and lower blood sugar
Iran J Reprod Med 2012
Medicines regulator Swissmedic told Reuters Bachem was authorised to export semaglutide, but added Swissmedic was "not supervising patents"